Assignee
TREMEAU PHARMACEUTICALS INC
US·8 granted patents·10 pending applications·25 citations·filing 2018–2022
Top patents by PatentIndex Score
18 records- 0196US11161833B1Deuterated etoricoxib, methods of manufacture, and use thereofTREMEAU PHARMACEUTICALS INC·Filed 2021·Granted Nov 2, 2021·4 cites·30 claims
- 0294US10987337B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·9 cites·28 claims
- 0393US11617735B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2022·Granted Apr 4, 2023·2 cites·28 claims
- 0493US11559509B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2022·Granted Jan 24, 2023·2 cites·25 claims
- 0592US10945992B1Dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2020·Granted Mar 16, 2021·6 cites·28 claims
- 0691US11576890B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·2 cites·32 claims
- 0780US11872206B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·36 claims
- 0873US2022409575A1Dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0971US11858909B2Deuterated etoricoxib, methods of manufacture, and use thereofTREMEAU PHARMACEUTICALS INC·Filed 2021·Granted Jan 2, 2024·0 cites·31 claims
- 1071US2022047542A1Novel dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1168US2021169845A1Novel dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1267US2021137878A1Novel dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1363US2021244672A1Ingestible Product and a Method of Using the SameTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1462US2022273609A1Treatment of viral hemorrhagic fevers with etoricoxibTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1558US2022125773A1Aqueous formulations of water insoluble cox-2 inhibitorsTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1657US2020323830A1Treatment of viral hemorrhagic fevers with etoricoxibTREMEAU PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1757US2020323813A1Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal anti-inflammatory drugsTREMEAU PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1855US2019083405A1Ingestible product and a method of using the sameTREMEAU PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TREMEAU PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →